Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (60)

2024

  1. Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity

    Brain, Behavior, and Immunity, Vol. 121, pp. 192-210

  2. Correction to: SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex (Acta Neuropathologica Communications, (2022), 10, 1, (180), 10.1186/s40478-022-01480-y)

    Acta Neuropathologica Communications

2023

  1. Aluminum alters excitability by inhibiting calcium, sodium, and potassium currents in bovine chromaffin cells

    Journal of Neurochemistry, Vol. 165, Núm. 2, pp. 162-176

  2. Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells

    GLIA, Vol. 71, Núm. 1, pp. 103-126

  3. Spatial organization of neuron-astrocyte interactions in the somatosensory cortex

    Cerebral cortex (New York, N.Y. : 1991), Vol. 33, Núm. 8, pp. 4498-4511

  4. The endocannabinoid system and autoimmune demyelination: A focus on multiple sclerosis

    Neurobiology and Physiology of the Endocannabinoid System (Elsevier), pp. 229-240

  5. Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 8, pp. 1301-1316

2022

  1. Assessing care-related regret among nurses specialized in multiple sclerosis: A psychometric analysis of a new assessment battery

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 8, Núm. 4

  2. Cannabinoid CB1 receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse

    Frontiers in Neuroanatomy, Vol. 16

  3. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

  4. Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells

    Frontiers in Immunology, Vol. 12

  5. SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex

    Acta Neuropathologica Communications, Vol. 10, Núm. 1

2021

  1. Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation

    npj Parkinson's Disease, Vol. 7, Núm. 1

  2. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

    Histochemistry and Cell Biology, Vol. 156, Núm. 5, pp. 479-502

  3. Regret and Therapeutic Decisions in Multiple Sclerosis Care: Literature Review and Research Protocol

    Frontiers in Neurology, Vol. 12

  4. Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo

    GLIA, Vol. 69, Núm. 3, pp. 532-545

2020

  1. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease

    Neurologia, Vol. 35, Núm. 3, pp. 185-206

  2. Gene expression analysis of astrocyte and microglia endocannabinoid signaling during autoimmune demyelination

    Biomolecules, Vol. 10, Núm. 9, pp. 1-19

  3. P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia

    Frontiers in Molecular Neuroscience, Vol. 13

  4. P2x7 receptors control demyelination and inflammation in the cuprizone model

    Brain, Behavior, and Immunity - Health, Vol. 4